|
UBE2R2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.465400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.566200E-01 |
| Normal-vs-Stage2 |
9.063200E-01 |
| Normal-vs-Stage3 |
7.388600E-01 |
| Normal-vs-Stage4 |
3.735000E-01 |
| Stage1-vs-Stage2 |
9.986400E-01 |
| Stage1-vs-Stage3 |
8.229000E-01 |
| Stage1-vs-Stage4 |
4.122200E-01 |
| Stage2-vs-Stage3 |
8.611400E-01 |
| Stage2-vs-Stage4 |
4.163400E-01 |
| Stage3-vs-Stage4 |
5.425600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.165400E-01 |
| Normal-vs-AfricanAmerican |
5.070400E-01 |
| Normal-vs-Asian |
8.309800E-01 |
| Caucasian-vs-AfricanAmerican |
9.275800E-01 |
| Caucasian-vs-Asian |
6.666200E-01 |
| AfricanAmerican-vs-Asian |
5.508000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.989200E-01 |
| Normal-vs-Female |
1.987630E-01 |
| Male-vs-Female |
2.648200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.936800E-01 |
| Normal-vs-Extreme_Weight |
7.017800E-01 |
| Normal-vs-Obese |
2.293200E-01 |
| Normal-vs-Extreme_Obese |
8.201200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.527200E-01 |
| Normal_Weight-vs-Obese |
5.823600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.360200E-01 |
| Extreme_Weight-vs-Obese |
1.374820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.447200E-01 |
| Obese-vs-Extreme_Obese |
4.538200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.122200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.101700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.445200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.725200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.874000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.237600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.368600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.404200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.163000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.976000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.335400E-01 |
| Normal-VS-Type2 PRCC |
8.913000E-01 |
| Normal-VS-KIRP CIMP |
2.100100E-02 |
| Normal-VS-Unclassified PRCC |
5.724400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.413400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.242040E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.581650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.921300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.449400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.089950E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.879400E-01 |
| Normal-vs-N1 |
6.092600E-01 |
| Normal-vs-N2 |
3.227000E-01 |
| N0-vs-N1 |
5.134400E-01 |
| N0-vs-N2 |
5.414600E-01 |
| N1-vs-N2 |
7.969600E-01 |
|
|
